ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,017Medicare Part D Prescriptions Filled, Including Refills

Rank: 70 out of 1290

$1M Total Retail Price of All Prescriptions

Rank: 49 out of 1290

905 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 905 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 8,910 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$100 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
PREDNISONE 693 644 1 21
SPIRIVA 439 359 2 75
ADVAIR DISKUS 339 293 3 37
AZITHROMYCIN 260 230 4 61
SINGULAIR 250 196 5 85
FUROSEMIDE 234 230 6 9
SIMVASTATIN 215 208 7 1
PROAIR HFA 205 190 8 73
OMEPRAZOLE 189 168 9 2
METOPROLOL TARTRATE 178 139 10 7
SYMBICORT 170 153 11 109
LEVOTHYROXINE SODIUM 165 149 12 4
IPRATROPIUM BROMIDE 158 113 13 158
VENTOLIN HFA 149 125 14 123
WARFARIN SODIUM 147 79 15 22
POTASSIUM CHLORIDE 140 127 16 35
AMLODIPINE BESYLATE 140 140 16 3
LISINOPRIL 139 129 18 5
ALBUTEROL SULFATE 130 87 19 319
LEVOFLOXACIN 121 113 20 150
MONTELUKAST SODIUM 109 84 21 189
ATORVASTATIN CALCIUM 94 85 22 23
FLUTICASONE PROPIONATE 91 72 23 26
HYDROCHLOROTHIAZIDE 90 90 24 20
DONEPEZIL HCL 86 86 25 13
COMBIVENT 76 66 26 215
ZOLPIDEM TARTRATE 75 68 27 15
METOPROLOL SUCCINATE 72 72 28 14
NYSTATIN 71 66 29 440
CLOPIDOGREL 64 58 30 24
DIGOXIN 64 59 30 51
NAMENDA 63 63 32 27
PANTOPRAZOLE SODIUM 61 43 33 48
FAMOTIDINE 60 59 34 128
LOSARTAN POTASSIUM 60 58 34 19
TRAMADOL HCL 60 58 34 25
MIRTAZAPINE 59 51 37 93
GABAPENTIN 59 52 37 8
AMOX TR-POTASSIUM CLAVULANATE 57 46 39 234
ALENDRONATE SODIUM 57 57 39 39
SPIRONOLACTONE 57 57 39 126
LEVETIRACETAM 56 45 42 70
DIOVAN 55 47 43 53
MUPIROCIN 52 50 44 120
CARVEDILOL 51 51 45 12
CIPROFLOXACIN HCL 51 44 45 46
SANTYL 51 51 45 486
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.